BUZZ-<a href="https://laohu8.com/S/ILMN">Illumina</a> rises after forecasting Q4 results beat** Shares of gene sequencing solutions company Illumina ILMN.O rise as much as 3.7% to $151
** Expects Q4 revenue of $1.16 billion vs. analysts' expectations of $1.10 billion, according to data compiled by LSEG
** Sees Q4 adj. EPS of $1.27 to $1.30 vs. estimates of $1.21
** Co introduces dataset that maps genetic changes to help accelerate drug discovery through AI, partnering with drugmakers AstraZeneca AZN.L, Merck MRK.N and Eli Lilly LLY.N
** ILMN up 6.5% over the past 12 months
(Reporting by Angela Christy in Bengaluru)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments